Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency

LeaderMed Group and OPKO Health Form Joint Venture to Develop and Commercialize Oxyntomodulin and Factor VIIa-CTP in China and Other Asian Territories

H.C. Wainwright 23rd Annual Global Investment Conference

Sep 13 – Sep 15, 2021

14th Annual Barrington Research Fall Conference

Sep 9, 2021